These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11399216)

  • 1. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.
    Neaigus A; Miller M; Friedman SR; Hagen DL; Sifaneck SJ; Ildefonso G; des Jarlais DC
    Addiction; 2001 Jun; 96(6):847-60. PubMed ID: 11399216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.
    Neaigus A; Gyarmathy VA; Miller M; Frajzyngier VM; Friedman SR; Des Jarlais DC
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):493-503. PubMed ID: 16652059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.
    Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Tross S; Perlman DC; Campbell AN; Cooper HL; Hagan H
    J Subst Abuse Treat; 2016 Dec; 71():48-53. PubMed ID: 27776677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin.
    Valdez A; Cepeda A; Neaigus A; Russell A
    Int J Drug Policy; 2008 Dec; 19(6):442-9. PubMed ID: 19038723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors).
    Valdez A; Neaigus A; Kaplan C; Cepeda A
    Drug Alcohol Depend; 2011 Apr; 114(2-3):233-6. PubMed ID: 21075561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.
    Gyarmathy VA; Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):448-56. PubMed ID: 12138352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
    Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
    De P; Jolly A; Cox J; Boivin JF
    Can J Public Health; 2006; 97(3):207-9. PubMed ID: 16827407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field Testing the "Avoid the Needle" Intervention for Persons at Risk for Transitioning to Injecting Drug Use in Tallinn, Estonia and New York City, USA.
    Jarlais DCD; McKnight C; Weng CA; Feelemyer J; Tross S; Raag M; Org G; Talu A; Uuskula A
    AIDS Behav; 2023 Nov; 27(11):3767-3779. PubMed ID: 37249805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injecting transition risk and depression among Mexican American non-injecting heroin users.
    Cepeda A; Kaplan C; Neaigus A; Cano MÁ; Villarreal Y; Valdez A
    Drug Alcohol Depend; 2012 Sep; 125 Suppl 1(0 1):S12-7. PubMed ID: 22749681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK.
    Strang J; Griffiths P; Powis B; Gossop M
    Am J Addict; 1999; 8(2):148-60. PubMed ID: 10365195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
    Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
    Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risk factors for injecting among Mexican American non-injecting heroin users.
    Valdez A; Neaigus A; Cepeda A
    J Ethn Subst Abuse; 2007; 6(2):49-73. PubMed ID: 18192204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors.
    Ross MW; McCurdy SA; Kilonzo GP; Williams ML; Leshabari MT
    Am J Trop Med Hyg; 2008 Sep; 79(3):338-43. PubMed ID: 18784224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitions between the injection of heroin and amphetamines.
    Darke S; Kaye S; Ross J
    Addiction; 1999 Dec; 94(12):1795-803. PubMed ID: 10717958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heroin users' careers and perceptions of drug use: a comparison of smokers and injectors in the Mersey region.
    Cousins P; Bentall RP
    Br J Addict; 1989 Dec; 84(12):1467-72. PubMed ID: 2611429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors.
    Gossop M; Griffiths P; Powis B; Williamson S; Fountain J; Strang J
    AIDS Care; 1997 Dec; 9(6):651-60. PubMed ID: 26672149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Tross S; Perlman DC; Campbell AN; Hagan H; Cooper HL
    Sex Transm Dis; 2017 Feb; 44(2):85-90. PubMed ID: 27898577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.